» Articles » PMID: 25310711

Suppressor of Cytokine Signaling 1 Counteracts Rhesus Macaque TRIM5α-induced Inhibition of Human Immunodeficiency Virus Type-1 Production

Overview
Journal PLoS One
Date 2014 Oct 14
PMID 25310711
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Old world monkey TRIM5α is a host factor that restricts human immunodeficiency virus type-1 (HIV-1) infection. Previously, we reported that rhesus macaque TRIM5α (RhTRIM5α) restricts HIV-1 production by inducing degradation of precursor Gag. Since suppressor of cytokine signaling 1 (SOCS1) is known to enhance HIV-1 production by rescuing Gag from lysosomal degradation, we examined if SOCS1 is involved in RhTRIM5α-mediated late restriction. Over-expression of SOCS1 restored HIV-1 production in the presence of RhTRIM5α to a level comparable to that in the absence of RhTRIM5α in terms of titer and viral protein expression. Co-immunoprecipitation studies revealed that SOCS1 physically interacted with RhTRIM5α. Over-expression of SOCS1 affected RhTRIM5α expression in a dose-dependent manner, which was not reversed by proteasome inhibitors. In addition, SOCS1 and RhTRIM5α were detected in virus-like particles. These results suggest that SOCS1 alleviates RhTRIM5α-mediated regulation in the late phase of HIV-1 life cycle probably due to the destabilization of RhTRIM5α.

Citing Articles

Production of Vesicular Stomatitis Virus Glycoprotein-Pseudotyped Lentiviral Vector Is Enhanced by Ezrin Silencing.

Izumida M, Togawa K, Hayashi H, Matsuyama T, Kubo Y Front Bioeng Biotechnol. 2020; 8:368.

PMID: 32411688 PMC: 7201057. DOI: 10.3389/fbioe.2020.00368.


Robust Enhancement of Lentivirus Production by Promoter Activation.

Suzuki N, Yoshida T, Takeuchi H, Sakuma R, Sukegawa S, Yamaoka S Sci Rep. 2018; 8(1):15036.

PMID: 30310119 PMC: 6181906. DOI: 10.1038/s41598-018-33042-5.

References
1.
Qian Y, Zhang Q, Cheng T, Wan H, Zhou M . RNA interference-mediated silencing of SOCS-1 via lentiviral vector promotes apoptosis of alveolar epithelial cells in vitro. Mol Med Rep. 2011; 5(2):452-6. DOI: 10.3892/mmr.2011.672. View

2.
Linossi E, Nicholson S . The SOCS box-adapting proteins for ubiquitination and proteasomal degradation. IUBMB Life. 2012; 64(4):316-23. DOI: 10.1002/iub.1011. View

3.
Rui L, Yuan M, Frantz D, Shoelson S, White M . SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2. J Biol Chem. 2002; 277(44):42394-8. DOI: 10.1074/jbc.C200444200. View

4.
Stratton M, Darling J, Pilkington G, Lantos P, Reeves B, Cooper C . Characterization of the human cell line TE671. Carcinogenesis. 1989; 10(5):899-905. DOI: 10.1093/carcin/10.5.899. View

5.
Palombella V, Rando O, GOLDBERG A, Maniatis T . The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B. Cell. 1994; 78(5):773-85. DOI: 10.1016/s0092-8674(94)90482-0. View